← Eichor
Study identifier: NCT04678154 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2

Condition: Post Operative Surgical Site Infection  ·  Sponsor: Major Extremity Trauma Research Consortium

PhasePhase 3
Planned participants600
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersNo

About this study

The PRCT evaluates infection outcomes as well as fracture and antibiotic-related complications to include the emergence of resistant bacteria associated with two different antibiotic strategies in the treatment of Gustilo type IIIB tibia and hindfoot fractures (calcaneus and talus) and selected IIIA fractures of the tibia and trauma-related transtibial amputations that are performed in the "zone-of-injury". This study will be conducted in established METRC level 1 trauma centers. The patients will be randomized as close to admission as possible to either 1) Standard of Care (SOC) prophylactic open fracture protocol, including the use of topical antibiotic as per the usual practice of the surgeon or 2) experimental protocol (SEXTANT). The SEXTANT protocol includes application of wound bioburden-targeted topical Vancomycin powder and Tobramycin powder antibiotic treatment at the time of final wound closure/coverage combined with 72 hours of systemic antibiotic coverage targeted to both gram-positive and gram-negative pathogens. The study will compare the results of the current SOC prophylactic coverage to the strategic wound bioburden treatment (SEXTANT) protocol. Up until the time of definitive wound closure/coverage, all patients will be treated per the usual regimen of the surgeon / center and in accordance with current Trauma Quality Improvement Program (TQIP) and Surgical Quality Improvement Program (SQIP) recommendations for the care of open fractures.14,15,17 It includ…

This description comes directly from the study's public registry record.

Talk to the study team

Suna Chung, MPH  ·  4105023357  ·  schung60@jhu.edu

Susan C Collins, MSc  ·  410-502-8966  ·  scolli21@jhu.edu

Always discuss trial participation with your own doctor first.

Locations (31)

Stanford UniversityRedwood City, California, United StatesRecruiting
_University of California, San FranciscoSan Francisco, California, United StatesRecruiting
University of California at San FranciscoSan Francisco, California, United StatesRecruiting
University of Colorado Anschutz Medical CampusAurora, Colorado, United StatesRecruiting
St Mary's University/Tenent HealthWest Palm Beach, Florida, United StatesRecruiting
Emory University School of MedicineAtlanta, Georgia, United StatesRecruiting
Indiana University School of Medicine - Methodist HospitalIndianapolis, Indiana, United StatesRecruiting
Indiana University/Eskenazi HealthIndianapolis, Indiana, United StatesRecruiting
University of KentuckyLexington, Kentucky, United StatesRecruiting
LSU Health SciencesNew Orleans, Louisiana, United StatesRecruiting
University of Maryland , MD Department of OrthopaedicsBaltimore, Maryland, United StatesRecruiting
Walter Reed Military Medical CenterBethesda, Maryland, United StatesRecruiting

+ 19 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04678154